First Manhattan’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $132M | Sell |
604,832
-1,634
| -0.3% | -$362K | 0.36% | 47 |
|
|
2025
Q4 | $139M | Sell |
606,466
-408
| -0.1% | -$92.9K | 0.36% | 45 |
|
|
2025
Q3 | $141M | Sell |
606,874
-2,818
| -0.5% | -$574K | 0.37% | 42 |
|
|
2025
Q2 | $113M | Sell |
609,692
-8,567
| -1% | -$1.59M | 0.32% | 44 |
|
|
2025
Q1 | $130M | Buy |
618,259
+11,326
| +2% | +$2.2M | 0.38% | 41 |
|
|
2024
Q4 | $108M | Sell |
606,933
-10,221
| -2% | -$1.88M | 0.32% | 46 |
|
|
2024
Q3 | $122M | Buy |
617,154
+5,565
| +0.9% | +$1.04M | 0.36% | 48 |
|
|
2024
Q2 | $105M | Sell |
611,589
-29,914
| -5% | -$4.96M | 0.34% | 47 |
|
|
2024
Q1 | $117M | Sell |
641,503
-8,564
| -1% | -$1.48M | 0.38% | 44 |
|
|
2023
Q4 | $101M | Sell |
650,067
-18,501
| -3% | -$2.7M | 0.35% | 45 |
|
|
2023
Q3 | $99.7M | Sell |
668,568
-216,897
| -24% | -$31.8M | 0.37% | 40 |
|
|
2023
Q2 | $119M | Sell |
885,465
-369,484
| -29% | -$54.2M | 0.44% | 39 |
|
|
2023
Q1 | $200M | Sell |
1,254,949
-38,417
| -3% | -$5.87M | 0.77% | 23 |
|
|
2022
Q4 | $209M | Sell |
1,293,366
-46,699
| -3% | -$7.16M | 0.77% | 21 |
|
|
2022
Q3 | $180M | Sell |
1,340,065
-61,538
| -4% | -$8.83M | 0.76% | 21 |
|
|
2022
Q2 | $215M | Sell |
1,401,603
-67,521
| -5% | -$10.3M | 0.87% | 20 |
|
|
2022
Q1 | $238M | Sell |
1,469,124
-194,394
| -12% | -$28.2M | 0.78% | 21 |
|
|
2021
Q4 | $225M | Buy |
1,663,518
+278,874
| +20% | +$32.9M | 0.74% | 25 |
|
|
2021
Q3 | $149M | Buy |
1,384,644
+55,311
| +4% | +$6.32M | 0.55% | 35 |
|
|
2021
Q2 | $150M | Buy |
1,329,333
+173,554
| +15% | +$19.5M | 0.55% | 37 |
|
|
2021
Q1 | $125M | Buy |
1,155,779
+37,955
| +3% | +$4.06M | 0.54% | 37 |
|
|
2020
Q4 | $120M | Buy |
1,117,824
+899,738
| +413% | +$86.5M | 0.57% | 32 |
|
|
2020
Q3 | $19.1M | Buy |
218,086
+3,754
| +2% | +$353K | 0.1% | 99 |
|
|
2020
Q2 | $21M | Sell |
214,332
-628
| -0.3% | -$55.3K | 0.12% | 92 |
|
|
2020
Q1 | $16.4M | Buy |
214,960
+211
| +0.1% | +$18K | 0.11% | 102 |
|
|
2019
Q4 | $19M | Buy |
214,749
+399
| +0.2% | +$33.1K | 0.1% | 110 |
|
|
2019
Q3 | $16.2M | Buy |
214,350
+46,057
| +27% | +$3.16M | 0.09% | 121 |
|
|
2019
Q2 | $12.2M | Buy |
+168,293
| New | +$13.2M | 0.07% | 149 |
|
|
2019
Q1 | – | Sell |
-164,998
| Closed | -$15.2M | – | 1374 |
|
|
2018
Q4 | $15.2M | Buy |
164,998
+3,552
| +2% | +$312K | 0.09% | 124 |
|
|
2018
Q3 | $15.3M | Buy |
161,446
+1,545
| +1% | +$147K | 0.08% | 143 |
|
|
2018
Q2 | $14.8M | Sell |
159,901
-126
| -0.1% | -$12.3K | 0.09% | 145 |
|
|
2018
Q1 | $15.1M | Buy |
160,027
+83,188
| +108% | +$9.14M | 0.09% | 144 |
|
|
2017
Q4 | $7.43M | Sell |
76,839
-199
| -0.3% | -$18.8K | 0.04% | 223 |
|
|
2017
Q3 | $6.84M | Buy |
77,038
+1
| +0% | +$76 | 0.04% | 219 |
|
|
2017
Q2 | $5.59M | Sell |
77,037
-2,801
| -4% | -$188K | 0.03% | 233 |
|
|
2017
Q1 | $5.2M | Sell |
79,838
-119,788
| -60% | -$7.53M | 0.03% | 238 |
|
|
2016
Q4 | $12.5M | Sell |
199,626
-956
| -0.5% | -$58.4K | 0.08% | 157 |
|
|
2016
Q3 | $12.7M | Sell |
200,582
-7,959
| -4% | -$515K | 0.08% | 155 |
|
|
2016
Q2 | $12.9M | Buy |
208,541
+37,936
| +22% | +$2.31M | 0.08% | 158 |
|
|
2016
Q1 | $9.74M | Sell |
170,605
-121,486
| -42% | -$6.77M | 0.06% | 167 |
|
|
2015
Q4 | $17.3M | Sell |
292,091
-273,649
| -48% | -$15.8M | 0.11% | 128 |
|
|
2015
Q3 | $30.8M | Sell |
565,740
-11,119
| -2% | -$724K | 0.2% | 83 |
|
|
2015
Q2 | $38.8M | Sell |
576,859
-43,211
| -7% | -$2.82M | 0.23% | 81 |
|
|
2015
Q1 | $36.3M | Sell |
620,070
-91,241
| -13% | -$5.51M | 0.21% | 84 |
|
|
2014
Q4 | $46.5M | Sell |
711,311
-3,210
| -0.4% | -$202K | 0.26% | 74 |
|
|
2014
Q3 | $41.3M | Buy |
714,521
+52,525
| +8% | +$2.92M | 0.24% | 79 |
|
|
2014
Q2 | $37.4M | Buy |
661,996
+74,677
| +13% | +$3.92M | 0.24% | 80 |
|
|
2014
Q1 | $30.2M | Sell |
587,319
-24,081
| -4% | -$1.22M | 0.2% | 96 |
|
|
2013
Q4 | $32.3M | Sell |
611,400
-3,358
| -0.5% | -$165K | 0.21% | 87 |
|
|
2013
Q3 | $27.5M | Sell |
614,758
-450
| -0.1% | -$19.9K | 0.19% | 90 |
|
|
2013
Q2 | $27.7M | Buy |
+615,208
| New | +$26.9M | 0.19% | 91 |
|
Other funds holding ABBV
VCM
VPM
First Manhattan's ABBV Position: Q1 2026 in Review
First Manhattan reduced its AbbVie (ABBV) stake by 0.27% in Q1 2026, selling an estimated $362K and leaving 604,832 shares worth $132M. The position accounts for 0.36% of the portfolio, ranked #47.
First Manhattan first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $238M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First Manhattan held 604,832 shares of AbbVie worth $132M as of Q1 2026.
- First Manhattan sold 1,634 AbbVie shares in Q1 2026, an estimated $362K.
- AbbVie made up 0.36% of First Manhattan's portfolio in Q1 2026, its #47 holding.
- First Manhattan first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- First Manhattan's AbbVie position peaked at $238M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.